Search Results 1531-1540 of 21366 for anti-TNF drugs

  1. Multi-center ESG Randomized Interventional Trial (MERIT-Trial) - Mayo Clinic

    Participation eligibility · 50 patients with hypertension on one or more anti-hypertensive medication; · 50 patients with type II diabetes mellitus on oral agents ...

  2. Research establishes strong association between family history and increased risk of colorectal cancer in patients with inflammatory bowel diseases - Mayo Clinic

    Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD · Video. Chromoendoscopy for inflammatory bowel disease. MAC ...

  3. Nuclear Medicine Therapy - Conditions treated - Mayo Clinic

    Learn of Mayo Clinic's capabilities in nuclear medicine therapy, including PRRT with Lutathera, which doctors use to treat neuroendocrine tumors.

  4. Flutamide (Oral Route) Description and Brand Names - Mayo Clinic

    Flutamide belongs to the group of medicines called antiandrogens. It works by blocking the effects of androgen (a male hormone), to stop the growth and spread ...

  5. Pembrolizumab (Intravenous Route) Description and Brand Names - Mayo Clinic

    Pembrolizumab injection is also used alone as first-line treatment for stage III NSCLC in patients who cannot have surgery or chemotherapy with radiation or for ...

  6. Study of DF9001 in Patients With Advanced Solid Tumors - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... Prior treatment with an anti-EGFR antibody is required for. RAS wild-type ...

  7. Cytomegalovirus (CMV) Infection Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate the safety and effectiveness of the VERIS CMV Assay as an aid in the management of anti-CMV treatment for solid ...

  8. Naltrexone And Bupropion (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  9. Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy - Mayo Clinic

    About this study. Pazopanib is FDA approved as a second line and beyond treatment for metastatic soft tissue sarcoma. There is a population of elderly and ...

  10. Spatial and Molecular Architecture of Tumor Environments Responsive to IO (immuno-oncology) Therapy - Mayo Clinic

    Recommendation by the treating provider to initiate therapy with a commercially available, FDA approved, anti-PD-1-based therapy or anti-PD-L1therapy; The ...